Neuroprotective Effects of Cistanches Herba Therapy on Patients with Moderate Alzheimer’s Disease

Figure 5

Changes of T-tau, TNF-α, and IL-1β in CSF of AD patients determined by ELISA assay. (a) T-tau. (b) TNF-α. (c) IL-1β. T-tau, TNF-α, and IL-1β concentrations had attenuated during 48 weeks compared with control group after drug treatments (). No statistical difference between DON treatment group and CH treatment group ().

(a)

(b)

(c)